PubRank

Wallace Akerley

Author PubWeight™ 96.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010 67.34
2 Non-small cell lung cancer. J Natl Compr Canc Netw 2010 3.93
3 Non-small cell lung cancer, version 2.2013. J Natl Compr Canc Netw 2013 2.56
4 Non-small cell lung cancer. J Natl Compr Canc Netw 2012 2.40
5 Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 2007 2.20
6 Small cell lung cancer. J Natl Compr Canc Netw 2013 2.04
7 Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer. J Clin Oncol 2006 1.84
8 Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw 2014 1.71
9 Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases. J Clin Oncol 2009 1.39
10 Small cell lung cancer. J Natl Compr Canc Netw 2011 1.07
11 Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2013 1.06
12 Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer. J Thorac Oncol 2009 1.04
13 Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol 2013 1.03
14 Malignant pleural mesothelioma. J Natl Compr Canc Netw 2012 1.01
15 Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017 0.99
16 NCCN Task Force Report: mTOR inhibition in solid tumors. J Natl Compr Canc Netw 2008 0.97
17 Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancer. Mol Cancer Ther 2010 0.93
18 Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer. Lung Cancer 2005 0.89
19 Small-cell carcinoma of the prostate. J Clin Oncol 2008 0.85
20 Squamous non-small cell lung cancer as a distinct clinical entity. Am J Clin Oncol 2015 0.82
21 Oncologists' current opinion on the treatment of colon carcinoma. Anticancer Agents Med Chem 2007 0.82
22 An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases. Lung Cancer 2012 0.82
23 Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005 0.82
24 Non-small cell lung cancer. J Natl Compr Canc Netw 2008 0.81
25 Thymic malignancies. J Natl Compr Canc Netw 2010 0.81
26 Small cell lung cancer. J Natl Compr Canc Netw 2008 0.78
27 The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. Semin Oncol 2009 0.77
28 A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis. Lung Cancer 2013 0.75